90
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum]

Pages 529-530 | Published online: 13 May 2022